Cerus

$7.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.41%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cerus and other stocks, options, and ETFs commission-free!

About CERS

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA. The listed name for CERS is Cerus Corporation Common Stock.

CEO

William Mariner Greenman

Employees

254

Headquarters

Concord, California

Founded

1991

Market Cap

1.22B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.83M

High Today

$7.38

Low Today

$7.14

Open Price

$7.14

Volume

1.20M

52 Week High

$8.87

52 Week Low

$2.71

Collections

Manufacturing

Research And Development

Technology

Health

Medical

CERS Earnings

-$0.13

-$0.09

-$0.04

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 18, After Hours